Interactions between the immune and nervous systems play an important role in modulating host susceptibility and resistance to inflammatory disease. Neuroendocrine regulation of inflammatory and immune responses and disease occurs at multiple levels: systemically, through the anti-inflammatory action of glucocorticoids released via hypothalamic-pituitary-adrenal axis stimulation; regionally, through production of glucocorticoids within and sympathetic innervation of immune organs such as the thymus; locally, at sites of inflammation. Estrogens also play an important role in immune modulation, and contribute to the approximately 2- to 10-fold higher incidence of autoimmune/inflammatory diseases seen in females of all mammalian species. During inflammation, cytokines from the periphery activate the central nervous system through multiple routes. This results in stimulation of the hypothalamic-pituitary-adrenal axis which, in turn through the immunosuppressive effects of the glucocorticoids, generally inhibits inflammation. Recent studies indicate that physiological levels of glucocorticoids are immunomodulatory rather than solely immunosuppressive, causing a shift in patterns of cytokine production from a TH1- to a TH2-type pattern. Interruptions of this loop at any level and through multiple mechanisms, whether genetic, or through surgical or pharmacological interventions, can render an inflammatory resistant host susceptible to inflammatory disease. Over-activation of this axis, as occurs during stress, can also affect severity of infectious disease through the immunosuppressive effects of the glucocorticoids. These interactions have been clearly demonstrated in many animal models, across species, strains and diseases, and are also relevant to human inflammatory, autoimmune and allergic illnesses, including rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, allergic asthma and atopic skin disease. While many genes and environmental factors contribute to susceptibility and resistance to autoimmune/inflammatory diseases, a full understanding of the molecular effects on immune responses of combinations of neuropeptides, neurohormones and neurotransmitters at all levels has opened up new therapeutic approaches and are essential for the design of future therapies based on such principles.

This article has been cited by other articles:

				B Boyle, K Koranyi, A Patocs, I Liko, A Szappanos, R Bertalan, K Racz, and C Balazs Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy Br. J. Ophthalmol., January 1, 2008; 92(1): 131 - 134. [Abstract] [Full Text] [PDF]

				E. M.J. Peters, S. Liotiri, E. Bodo, E. Hagen, T. Biro, P. C. Arck, and R. Paus Probing the Effects of Stress Mediators on the Human Hair Follicle: Substance P Holds Central Position Am. J. Pathol., December 1, 2007; 171(6): 1872 - 1886. [Abstract] [Full Text] [PDF]

				B. Mravec Letter To the Editor: Autonomic dysfunction in autoimmune diseases: consequence or cause? Lupus, September 1, 2007; 16(9): 767 - 768. [PDF]

				G. Huff, W. Huff, N. Rath, A. Donoghue, N. Anthony, and K. Nestor Differential Effects of Sex and Genetics on Behavior and Stress Response of Turkeys Poult. Sci., July 1, 2007; 86(7): 1294 - 1303. [Abstract] [Full Text] [PDF]

				E Giustarini, A Pinchera, P Fierabracci, M Roncella, L Fustaino, C Mammoli, and C Giani Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur. J. Endocrinol., May 1, 2006; 154(5): 645 - 649. [Abstract] [Full Text] [PDF]

				J. Ouyang, T. Jiang, M. Tan, Y. Cui, and X. Li Abnormal Expression and Distribution of Heat Shock Protein 90: Potential Etiologic Immunoendocrine Mechanism of Glucocorticoid Resistance in Idiopathic Nephrotic Syndrome Clin. Vaccine Immunol., April 1, 2006; 13(4): 496 - 500. [Abstract] [Full Text] [PDF]

				L. Motterle, Y. Diebold, A. Enriquez de Salamanca, V. Saez, C. Garcia-Vazquez, M. E. Stern, M. Calonge, and A. Leonardi Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol, April 1, 2006; 124(4): 462 - 468. [Abstract] [Full Text] [PDF]

				R. Campos-Rodriguez, A. Quintanar-Stephano, R. A. Jarillo-Luna, G. Oliver-Aguillon, J. Ventura-Juarez, V. Rivera-Aguilar, I. Berczi, and K. Kovacs Hypophysectomy and Neurointermediate Pituitary Lobectomy Reduce Serum Immunoglobulin M (IgM) and IgG and Intestinal IgA Responses to Salmonella enterica Serovar Typhimurium Infection in Rats Infect. Immun., March 1, 2006; 74(3): 1883 - 1889. [Abstract] [Full Text] [PDF]

				S Vale Psychosocial stress and cardiovascular diseases Postgrad. Med. J., July 1, 2005; 81(957): 429 - 435. [Abstract] [Full Text] [PDF]

				A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF]

				L. M. L. van Winsen, D. F. R. Muris, C. H. Polman, C. D. Dijkstra, T. K. van den Berg, and B. M. J. Uitdehaag Sensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 734 - 740. [Abstract] [Full Text] [PDF]

				T. Y. Zhang, X. Ding, and R. A. Daynes The Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type I by Lymphocytes Provides a Novel Means for Intracrine Regulation of Glucocorticoid Activities J. Immunol., January 15, 2005; 174(2): 879 - 889. [Abstract] [Full Text] [PDF]

				A. S. Kaugars, M. D. Klinnert, and B. G. Bender Family Influences on Pediatric Asthma J. Pediatr. Psychol., October 1, 2004; 29(7): 475 - 491. [Abstract] [Full Text] [PDF]

				B. D. Naliboff, M. Mayer, R. Fass, L. Z. Fitzgerald, L. Chang, R. Bolus, and E. A. Mayer The Effect of Life Stress on Symptoms of Heartburn Psychosom Med, May 1, 2004; 66(3): 426 - 434. [Abstract] [Full Text] [PDF]

				D Buljevac, W C J Hop, W Reedeker, A C J W Janssens, F G A van der Meche, P A van Doorn, and R Q Hintzen Self reported stressful life events and exacerbations in multiple sclerosis: prospective study BMJ, September 20, 2003; 327(7416): 646. [Abstract] [Full Text] [PDF]

				K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF]

				P. H. Wirtz, R. von Kanel, P. Schnorpfeil, U. Ehlert, K. Frey, and J. E. Fischer Reduced Glucocorticoid Sensitivity of Monocyte Interleukin-6 Production in Male Industrial Employees who are Vitally Exhausted Psychosom Med, July 1, 2003; 65(4): 672 - 678. [Abstract] [Full Text] [PDF]

				R. Sakumoto, E. Kasuya, T. Komatsu, and T. Akita Central and peripheral concentrations of tumor necrosis factor-{alpha} in Chinese Meishan pigs stimulated with lipopolysaccharide J Anim Sci, May 1, 2003; 81(5): 1274 - 1280. [Abstract] [Full Text] [PDF]

				C.-M. Hogerkorp, S. Bilke, T. Breslin, S. Ingvarsson, and C. A. K. Borrebaeck CD44-stimulated human B cells express transcripts specifically involved in immunomodulation and inflammation as analyzed by DNA microarrays Blood, March 15, 2003; 101(6): 2307 - 2313. [Abstract] [Full Text] [PDF]

				L. Wang, H. Das, A. Kamath, L. Li, and J. F. Bukowski Human V{gamma}2V{delta}2 T Cells Augment Migration-Inhibitory Factor Secretion and Counteract the Inhibitory Effect of Glucocorticoids on IL-1{beta} and TNF-{alpha} Production J. Immunol., May 15, 2002; 168(10): 4889 - 4896. [Abstract] [Full Text] [PDF]